13F Data
13F filer · CIK 1574661

March Altus Capital Management LP

Greenwich, CT · filing since Q4 2013 · last filing Nov 7, 2016
Reported value
$12.9M
+$3.3M vs prior
Positions
8
New / sold out
1 / 2
Added / reduced
3 / 1
Turnover
18.5%
buys $4.6M · sells $2.1M
Top-10 weight
100.0%

Biggest buys vs Q1 2016

ChangeSecurityShares changeChange %Est. trade value
AddedACADIA PHARMACEUTICALS INC+61,171+283.8%+$2.0M
NewJNJJOHNSON & JOHNSON+13,000–+$1.6M
AddedALIGN TECHNOLOGY INC+11,953+222.8%+$962.8K
AddedEDWARDS LIFESCIENCES CORP+1,168+6.7%+$116.5K

Biggest sells vs Q1 2016

ChangeSecurityShares changeChange %Est. trade value
Sold outREGENERON PHARMACEUTICALS-2,291-100.0%$-826.0K
Sold outATHENAHEALTH INC-4,900-100.0%$-680.0K
ReducedDEXCOM INC-7,346-38.6%$-582.7K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2013: $330.2MQ1 2014: $311.5MQ2 2014: $272.9MQ3 2014: $251.3MQ4 2014: $219.0MQ1 2015: $15.9MQ2 2015: $17.2MQ3 2015: $17.0MQ4 2015: $10.9MQ1 2016: $9.7MQ2 2016: $12.9MQ3 2016: $16.0M
Q4 2013Q3 2016

Holdings · Q2 2016

#SecuritySharesValueWeight
1ACADIA PHARMACEUTICALS INCCOM82,723$2.7M20.75%
2LLYLILLY ELI & CO26,810$2.1M16.32%
3EDWARDS LIFESCIENCES CORPCOM18,611$1.9M14.35%
4JNJJOHNSON & JOHNSON13,000$1.6M12.19%
5ALIGN TECHNOLOGY INCCOM17,319$1.4M10.78%
6ARATANA THERAPEUTICS INCCOM218,515$1.4M10.67%
7ALEXION PHARMACEUTICALS INCCOM8,599$1.0M7.76%
8DEXCOM INCCOM11,700$928.0K7.17%